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INTRODUCTION/SUMMARY
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I
1.1 Description of Experiment
There are 3 parts to the IML-2 TX-101 experiment. Part 1 is a pituitary cell
culture experiment. Part 2 is a pituitary cell separation experiment using the Japanese
free flow electrophoresis unit (FFEU). Part 3 is a pituitary secretory granule separation
experiment using the FFEU.
The objectives of this three part experiment are:
• to determine the kinetics of production of biologically active growth
hormone (GH) and prolactin (PRL) in rat pituitary GH and PRL cells in
microgravity (/Jg)
• to investigate three mechanisms by which a pg-induced lesion in
hormone production may occur. Mechanism #1 tests the hypothesis
that production of biologically active hormones in pg depends upon
paracrine interactions between cell populations in the culture vessel.
Mechanism #2 tests the hypothesis that secretory mechanism(s) in
GH/PRL cells in pg are different than in cells in Earth's gravity (lg); this
difference will be reflected in changes in electrophoretic mobilities of
ceils separated in pg. Mechanism #3 tests the hypothesis that #,g-
induced changes in hormone packaging within subcellular organelles will
be reflected in diff6re/qces in electrophoretic mobilities of these
organelles electrophoresed in flight vs. ground.
• to determine the quality of separations of pituitary cells and organelles
by continuous flow electrophoresis (CFE) in/Jg under conditions where
buoyancy-induced convection is eliminated.
The experiments described herein will be accomplished in two pieces of flight
hardware that have been designed and tested by NASDA. One of these is a cell
culture kit (CCK) which not only permits cell photography in flight, but also allows
change out of culture media and storage of the spent media for subsequent analysis
at lg. The second is a free flow electrophoresis unit that not only separates biological
particles (cells/secretory granules), but also allows for continued cell culture and/or
storage in/_g prior to return to Earth. It is important to emphasize that the designs
of these two pieces of flight hardware, for the first time, permit the experimenter to
do reasonably complex sets of coupled methodologies in /zg that are now done
routinely in biotechnology labs on earth. A successful experiment witl demonstrate
that these new approaches can be useful to probe mechanisms by which/Jg affects
cellfunction. As such, this biotechnology experiment serves as a precursor to similar
experiments that will certainly be done on Space Station Freedom.
1.2_ Scientific Knowledge to be Gained
In man, both GH and PRL are multifunctional hormones that are essential for
life. While their existence has been known for 25-50 years, the biochemical details
and functional significance of molecular events involved in their synthesis and release
from the GH/PRL cell are still incompletely understood. Moreover, the body targets
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for these two hormones are numerous. Our understanding of the ultimate
consequences of binding of these hormones to different tissues is also incomplete.
It is obvious that the methodological approaches used to study mammalian
pituitary cell function on earth have both advantages and disadvantages; the quality
of an experimental result depends upon the limitations of the method(s) used and an
awareness of those limitations (Appendix- Table 1). The Pl's laboratory has used
many of these different methodologies to develop this data base. Our current
understanding of pituitary cell function establishes the complexity and heterogeneity
of the pituitary GH and PRLsystems. Heterogeneity exists in 1)the molecular forms
(isoforms/variants) of GH and PRL; 2) the specialized subpopulations of GH/PRL cells
that may process these isoforms differently; 3) the geographic location of these cell
subpopulations within the pituitary gland and finally 4) in the biological potency of the
secreted hormone variants.
Since GH and PRL affect a number of organs in the body that are known to
change in/lg, the rationale for evaluating the biological potencies of these hormones
is obvious. Representative activities and bioassays for GH and PRL are shown in
Appendix Table-2.
Why Spaceflight?.? The previous pituitary data #rgumenl;. Rats and rat pituitary
cells have been "flown" under both pg and/Jg-mimicked conditions (Appendix-Table
3). Hymer, the PI of the experiment to be done on the IML-2 mission, has also been
PI or Co-I on each of these previous 5 spaceflights involving pituitary tissue. The
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results of these missions have been
ShellenbergerandR. Grindeland. 1992.
In press.) and described individually in
reviewed recently (Hymer, W. C., K.
Pituitary Cells in Space. Adv. Space R_s.
several refereed journal articles. Take____.0_n
togeth_er, the results demonstrate r_epeatable an(i _tatistically significant ohanges in
the pituitary GH and PRL c_ll systems. (Appendix Figs. 1,2, Tables 4,5.) They
therefore provide one experimental rationale for the IML-2 science. The reader will
note that virtually all of the data shown in Appendix Figs. 1 and 2 and Tables 4 and
5 were obtained on pituitary cells prepared from sp#ceflown rats postflight. A
successful IML-2 experiment requires that similar changes occur within spacefl0wn
pituitary c_ells themselves. On the 8 day mission of STS-46 (July, 1992) the PI
conducted an experiment (sponsored by NASA Code SB) which flew 165 glass vials,
each containing 2x105 rat pituitary cells. Test variables included culture medium, GH
cell subpopulations, GH cell position, GH cell sensitivity to hydrocortisone and finally
sensitivity of flight cells to hypothalamic peptides (GRF) postflight. Each of these
variables was assessed relative to the biologic potency of secreted GH and PRL during
flight. Many of the > 2000 samples generated are in assay at the time of writing this
science requirements document. However, key findings to date are summarized in
Appendix Table 6. They clearly show that /lg-induced changes occur _ the
pituitary GH/PRL cell and obviously strongly support the idea that the changes seen
in pituitaries of spaceflown rats are explicable by changes within the pituitary cells
themselves. This is a critically important result because it also establishes the first
requirement of a successful IML-2 experiment, vi____zthat in order to test for mechanisms
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which may explain our previous/_g results, similar changes must occur within the cells
themselves.
Why Spaceflight? The Data Base Argument. Intracellular biological processes
(and mechanisms controlling them) are often very different in the /Jg environment.
Dickson (ASGSB Bulletin 4(2) 151, 1991) has conveniently summarized the results
of over 500 spaceflight experiments (beginning in 1960) in which cells have been
exposed to _,g. There is no question that many different bacterial and mammalian cell
types "sense" /jg and respond differently. Going to space therefore provides a
laboratory environment that will eventually help define the role that gravity plays in
driving these processes on earth.
Whv spaceflight? The continuous flow electrophoresis (CFE) process
argument. While CFE has been used to separate cells and organelles in the past
(examples; Hannig etal., Electrophoresis 11, 600, 1990; Heidrich _., Methods in
Enzymologv 171, 513, 1989; Clifton etal., Electroph0resis 11, 913, 1990), there is
agreement that gravity limits resolution of separation because of: a) sedimentation
during exposure to the electric field, b) zone sedimentation due to density gradients
caused by diffusion boundaries (droplet effect), and c) convection due to heating of
the suspending medium by the electric current. The interesting experiment by Hannig
et al. (Electrophoresis, 1990) clearly establishes the fact that in the case of cell
separation resolution is better in/Jg. Previous results on the McDonnell Douglas CFES
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device also demonstrate the pg advantage in terms of protein concentration. Finally,
the PI conducted a pituitary cell separation experiment using CFES on STS-8. The
result demonstrated cell separation in pg but low yields required substantial cell
pooling. This, in turn, did not allow us to make statements concerning enhanced
resolution in space. (See Appendix Fig. 4A, 4B and 4C for data which substantiate
these claims).
It is well known that many harmful effects (e.g. electroosmosis, sedimentation,
Joule heating, natural convection and electrohydrodynamics) create problems for
separation of biologics by CFE. In the recent theoretical/experimental study by Clifton
et al (Electrophoresis, 11, 913, 1990) one finds: "The aim of this study was to
provide some quantitative information dealing with the influence of the main
parameters, such as chamber geometry and operating conditions, on the performance
of continuous flow electrophoresis. A model was presented that can determine the
conditions under which any instability due to natural convection may occur and
disturb the flow pattern inside the chamber. It was found that the existence of
instabilities is directly correlated to a dimensionless group, Gr/Re, which is strongly
dependent on the chamber geometry, i.e., its thickness, as well as on the operating
conditions, i.e. the product ET of the electric field strength times the residence time.
A model was also developed which distributes the products in a cross section near the
outlet of the electrophoretic chamber, under such conditions that no instability
disturbs the flow. This model takes account of diffusion, electroosmosis, migration
and three-dimensional flow map of the carrier fluid, assuming that
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electrohydrodynamics is negligible. The results that come from that model were
compared with experimental ones obtained for various chamber geometries, operating
conditions, and proteins. It was found that there is good agreement between
theoretical and experimental results, even when working with a mixture of several
kinds of proteins (hemoglobin, bovine serum albumin and cytochrome C)." Clifton
concludes: "If instabilities due to natural convection are to be feared, there are two
possible solutions: (i) operate in microgravity, where the conditions for flow stability
are easier to fulfill; (ii) operate on earth with a thinner chamber so as to keep a stable
flow pattern, but, in this case, only a partial separation can be obtained."
In conclusion, the variables associated with CFE at lg and pg include not only
1 ) confounding forces within the electrophoresis chamber (see above) but also 2) the
biologic complexities associated with protein molecules -* cells themselves. Indeed,
issues relating to interactions between sample and carrier buffer (conductivity
mismatches, electrohydrodynamics) are the primary focus of the other electrophoresis
experiment being done on the IML-2 mission (R. Snyder, PI; Ramses hardware). We
expect that the electrophoresis data obtained using model particles (polystyrene latex),
coupled with data using relevant biological particles (pituitary cells/subcellular
organelles), will permit a more thorough understanding of the advantages of CFE in
space.
1.3 Value of Knowledge tO Scientific FiQId
Snyder states "increased product yield can be as important as high resolution
for many biological materials and increased sample concentration is the main
mechanism for providing increased throughput in space"; (see Science Requirements
Document, IML-2). In the field of biotechnology however, existing cell separation
methods (flow cytometry, density gradient centrifugation, elutriation) on earth are
sometimes insufficient to obtain minority cell subpopulations of high scientific interest
(e.g. cells of the immune system) or organelles/proteins of similar importance. Results
of cell -_ protein separations by CFE on earth are relatively unknown in the science
community even though some laboratories have been "in the game" for > 15 years.
The fact that CFE equipment is relatively expensive has hindered its development. In
space the situation is worse although some preliminary results have been encouraging
(Appendix Fig. 4A). It is important to note that several countries have taken serious
interest in CFE in/Jg. Japan flew FFEU for the first time on the SL-J mission in 1992;
Germany has flown its unit on sounding rockets; France will fly its RAMSES unit on
IML-2 and the Russians have flown their unit on MIR many times. At Penn State
University, the Center for Cell Research is building its flight unit for use on several
SpaceHab missions beginning in 1994.
1.4. Justification of the Nee.d for the S.p.ac.e Environment
In Section 1.2 three arguments are offered as justification for spaceflight.
These are:
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• the previous pituitary data argument
• the data base argument
• the CFE process _ argument
It is not necessary to repeat these arguments again in this section. However,
an additional justification argument, somewhat more general in nature, now follows.
The PI has completed pituitary based experiments on 6 Code S-sponsored
spaceflights and 2 Code C-sponsored spaceflights. The !ML-2 experiment has evolved
naturally from these previous missions. Only a few investigators have had the
opportunity to participate in as many experiments. Since the focus of these previous
efforts has been varied (i.e. electrophoresis, cell culture, rats), and since different
experimental approaches are probably required to eventually understand how the
pituitary gland "works" (Appendix Table 1), our repeatable findings establish a
pituitary/Jg data base that pertains directly to the TX-101 experiment. With that
knowledge we can now begin to ask mechanistic questions about changes in the
GH/PRL cell systems in/]g. We no longer have to phrase the experimental question
in the form".., what is the effect ofpgexposureon...?" To the scientist unfamiliar
with the peculiarities and difficulties associated with pg experimentation, the
argument may not seem particularly strong. However, an experiment such as TX-
101, which calls for numerous, complex sets of tasks which include transfer of
samples from one piece of hardware to another, becomes technically demanding. As
a demonstration experiment for future pg research, the potential benefits become
greater too. A successful experiment will help meet the following goals.
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EXPERIMENTAL GOALS
establish the kinetics of release
of bioactive GH/PRL in pg
establish electrophoretic mobili-
ties of the pituitary cells in space
after 5 mission days; a time
when bioactive hormone output
is probably changing as well
establish electrophoretic
mobilities of pituitary organelles
in /Jg prepared from/.tg-exposed
cells
demonstrate enhanced resolution
of separation CFE using process
on two different biological
particles (granules/cells)
Coupled
stration
hardware
technology demon-
using Japanese
IMPLICATIONS
if changes are more significant in
media from 3rd culture change
than 1st, then countermeasure
strategy may be different
CFE would be useful tool for
indicator of cellular dysfunction
in pg
CFE would be useful tool for
preparation of cell organelles for
eventual study on earth or in
space
define utility of space CFE in
future biotech-nology
experiments
an example for future
nology research on SSF
biotech-
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BACKGROUND
2.1 Description of Scientific Field to Which Experiment Belongs
Modern biology uses techniques and approaches which are usually classified
as belonging to the fields of molecular and/or cellular biology. More traditional
designations of biological sciences; e.g. biochemistry, physiology, etc. use techniques
which cut across these molecular and cell biology fields. To make matters slightly
more confusing, the field of biotechnology has evolved from its gene-splicing origins
to investigations which use combinations of state of art technologies to obtain
answers to biological problems which can have both basic and practical applications
as end goals.
The TX-101 experiment uses two techniques, viz. cell culture and continuous
flow electrophoresis to determine 1) mechanisms by which pg affects pituitary cell
function and 2) efficiency of operation in this environment. It can be argued that the
former goal is basic in character; the later is more applied (i.e. biotechnological).
2.2 Current Applications for Research in Fi_eld
Heterogeneity is the hallmark of biological systems. It occurs at all levels; from
molecules (isoforms) to subpopulations of cells which reside in tissues. Moveover,
it is common among many organ systems (e.g endocrine, immune, musculoskeletal,
etc)--many of which are affected by/Jg. Accordingly, the TX-101 experiment has
widespread applications for this scientific field (section 2.1) on earth and in space.
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2.3 Brief Historical Account of Prior Research
• The PI has done pituitary research for over 30 years (see resume).
• The PI has participated in 8 previous spaceflights, each involving the
pituitary gland.
Current Research
In the Pl's laboratory, current research projects involve:
• study of pituitary-immune interrelationships, especially the role that
prolactin plays in modulating function of T-lymphocytes. Special
emphasis is placed on importance of these findings to breast cancer. Dr.
Andrea Mastro, Co-I of the TX-101 experiment, is also Co-I of this NIH-
sponsored grant.
• postflight analyses of the PHCF experiment (Pituitary Hormone Cell
Function) done on the STS-46 flight, July 1992.
• human growth hormone studies in relation to activities sponsored by
NASA's Office of Commercial Programs via a commercial development
of space grant to W. C. Hymer (PI) at Penn State's Center for Cell
Research.
2.4
2.5 Relationshio of Proposed Experiment to Scientific Field
See Section 2.1
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2.6 Anticipated Advance i._ State of the Art
The results will help determine the usefulness of separation technology by
continuous flow electrophoresis in space when applied to biologic samples that have
medical relevance for astronauts and people on earth.
JUSTIFICATION FOR CONDUCTING THE EXPERIMENT IN SPACE
3.1 Limitations of Ground-based Testing
Some of the complex forces controlling separation efficiency of biological
samples in/Jg are reduced. Thus not only can one begin to sort out and understand
the variables which confound separations on earth, but one can also begin to
determine the unique advantages of applying electrophoresis technology in space (see
Section 1.2). Our preflight data collected thus far (see Section 4.5) on CFES/FFEU
hardware demonstrate the limitations of these devices on earth. With specific
reference to pituitary cells/granules, preflight experiments show that cell
sedimentation leads to poor cell recoveries which in turn require sample pooling, thus
diminishing quality of the separation.
3_.2 Limitations of Drop Towers
The residence time for a CFE process is several minutes; the drop tower is not
a valid test vehicle.
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3.3 Limitations of Testing in Aircraft
Not a valid test vehicle for the identical reason given in 3.2.
3.4 Need for Accommodations in the Shuttle
The time, environmental and power requirements for the experiments in TX-101
can only be met in the Space Shuttle.
3.5 Limitations of Mathematical Modeling
There are no models that predict electrophoretic behavior of pituitary
cells/organelles in a way that predicts meaningful separations in terms of particle
function (i.e. the heterogeneity issue, section 2.2). General models recently published
by Albrecht-Brehler and Kondepudi (ASGSB Bulletin 4(2) 119, July 1991) address the
issue of ability of biologic particles in the cell _ organelle size range to "sense"/Jg.
Results of the TX-101 experiment may be interpretable in terms of these models; as
such they may provide data to establish to utility of these models in future missions.
In a similar vein, the results from TX-101 may be applicable and tested against
the mathematical models being developed for CFE by Dr. Snyder on his IML-2
experiment. Dr. Snyderis also Co-lofTX-101.
3.6 Limitations of Other Modeling Approaches
Not applicable.
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EXPERIMENT DETAILS
4.1
tWO,
Experiment Procedures to be Used
There are 3 parts to the experiment and each part interrelates with the other
PART i. PITUITARY CELL CULTURE IN JAPANESE CELL CULTURE KIT (CCK).
Background Rationale
While the techniques associated with pituitary cell culture are well established
(>20,000 publications have appeared in the literature between 1973-1991), the
pituitary cell system is complex, heterogeneous and incompletely understood. It has
been used primarily to test how hormones isolated from brain tissue regulate the
synthesis and release of pituitary hormones.
The Pl's interest in the use of pituitary cell culture technology stems from two
facts regarding biological heterogeneity in this system; first, that at least two
subpopulations of both GH and PRL cells are contained in the rat pituitary and s.econd,
that the biological (B) and immunological (I) activities of GH and PRL secreted from
these cells are not necessarily equal (i.e.B/l# 1). An understanding of the functional
significance of this heterogeneity, as well as mechanisms involved, is relevant to both
the medical and basic science community.
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In section 1.2, the rationale and preliminary results (Appendix Table 6) from the
STS-46 pituitary cell culture experiment were considered. There is now no longer any
doubt that pituitary cells, by themselves, function differently in/_g. It seems possible
that altered bioactivity of GH/PRL molecules in /_g may contribute to some of the
better known defects in target tissues in /Jg, viz the musculoskeletal and immune
systems.
Hvootheses Under Test
• The changes observed in previous spaceflight missions involving rats are
attributable to intracellular mechanisms originating within the pituitary
gland. These changes do not depend upon blood-mediated factors or
events.
• GH and PRL cells in the Japanese culture hardware will release less
bioactive GH and PRL in microgravity.
• Bioactive hormone levels will continue to change in/Jg; this change will
be reflected in culture media collected at different times in flight
GH and PRL cells in the Japanese culture hardware will not be able to
release as much bioactive GH and PRL on return to Earth as control cells
which have never been in space. That is, their "recovery" kinetics will
be different from control.
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Prefliaht Preparation
At L-36 hrs. 100 young (200 g) adult male SPF rats are killed and 3x108 sterile
anterior pituitary cells are prepared by trypsinization.
• -70x106 cells are seeded into each of two cell culture hardware units
(CCK), each containing 20 ml of medium (o= MEM + 5% calf serum +
antibiotics + 25mM Hepes, pH 7.4).
• One of the cell culture units is kept on the ground (Hanger L) @ 37°C;
the other is turned over to STS (37°C) at L-32 hrs. The later CCK is
used for Part I.
• The remaining cells (-1.9 x 108 ) are distributed equally into two
additional cell culture units (0.95 x 108/chamber)in medium (above) and
placed onboard STS. These two chambers will serve as the experimental
material for Parts fl and Ill respectively.
PARTII: PITUITARY CELL SEPARATION IN MICROGRAVlTY
Backgrouqd Rationale
The PI has over 20 years experience in the field of pituitary cell separation.
Techniques developed in my laboratory for pituitary tissue include separations which
are based on differences in a) cell size (velocity sedimentation at unit gravity); b) cell
density (density gradient centrifugation); c) cytoplasmic secretory granule content
(laser light scatter) and d) cell surface charge (continuous flow electrophoresis).
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Results from numerous studies document the usefulness of these cell separation
techniques for the study of functional heterogeneity of specific hormone-producing
cell types. For example, a subpopulation of GH cells which release hormone that is
rich in bioactivity (i.e. has a high B/I activity ratio) can be separated from a
subpopulation which releases GH with a low B/I activity ratio by either density
centrifugation or continuous flow electrophoresis. Mechanism(s) which account for
these consistent subpopulation differences in both GH and PRL cell subtypes are
unknown.
A continuous flow electrophoresJs device (McDonnelJ DougJas Corporation) was
used on the STS-8 mission (1983) in an effort to determine the role that gravity might
play in earth based separations. We determined that the quality of the cell separations
were of the same order on the earth as they were in space. This result was important
in the sense that it established that electrophoretic separations achieved in spaceflight
were based on differences in surface charge and not (as we seriously considered) due
to "fall back" of GH cells in the electrophoresis column during earth based runs.
Unfortunately, technical problems encountered during the experiment prohibited
answers relating to issues of subpopulation differences, B/I activities and cell-cell
communication differences. These can now be elaborated in the IML-2 mission.
Hypotheses Under Test
• The efficiency of the cell separation device (FFEU) in space will be
superior to that on the ground (as evidenced by the higher purity of GH
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and PRLcell containing fractions). High quality cell separations can be
achieved in spaceflight under conditions where cells are exposed to low
conductivity buffers for <60 minutes over the course of a 13 day
mission.
The most electrophoretically mobile (anodal) GH cell subpopulations will
be most negatively affected in terms of abilities to produce bioactive GH.
The electrophoretic mobility of spaceflown GH cells will be altered
because of hormone differences on the cell surface.
PART II1' PITUITARY SECRETORY GRANULE SEPARATION
IN MICROGRAVlTY
Backqround
The PI was among the first (1963) to show that GH-containing granules could
be isolated from rat pituitary tissue and that, after injection into hypophysectomized
rats, these particles were able to promote body
studies by many investigators show that"
growth. Results of subsequent
the intragranular pH is 5.
the H20 content is low (1 /11)
divalent cations are copackaged
the hormone is probably packaged in a crystalline state
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• various pumps (H+, Ca+2) are probably contained in the granule
membrane
Recent work in the Pl's laboratory show that:
• Zn +2 (0.2mM) stabilizes immunoactive GH in the particle
• GH extracted from cells with large numbers of secretory granules show
(by Western blotting) otigomeric forms of monomeric (22K) GH whereas
GH extracted from cells with fewer numbers of secretory granules do not
show aggregated hormone
• Lysates (containing granules) run on the McDonnell Douglas continuous
show heterogeneity in electrophoreticflow electrophoresis system
mobility.
As indicated in Appendix Table 4,
consistently more intensely stained with
GH cells prepared from flight rats are
fluoresceinated antibody to GH than
corresponding cells from ground control animals. Since a majority of intracellular
hormone is stored in the secretory granule, we believe the result can be attributed (in
part) to different packing of GH molecules within the granule in space.
Hypotheses Under Test
• Cross-linking of intragranular GH monomers via S-S bridging will be less
efficient in space. This, in turn, will expose more epitopes and decrease
bioactivity of the GH.
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• Organelles prepared in _g from space flown cells will have different
electrophoretic mobilities than ground based controls.
4.2 Measurements required
The statements and ideas presented in this section are based on two years of
preflight research and extensive discussions and planning with several individuals
within NASDA (primarily Drs. Nagoaka, Mukai, Kumei and Kobayashi). These
statements and ideas are also a consequence of data collected from samples
electrophoresed on Japanese flight hardware. These statements represent the Pl's
current understanding of events that will occur on the IML-2 mission. They are not
to be considered as being "cast in stone." Material presented below will be cross-
referenced with that in sections 4.5 and 4.6.
PART 1 - MEASUREMENTS
on every 3rd mission day (3 times total), the 20 ml of culture fluid will
be removed from the chamber and transferred to a storage tube (stored
frozen on Shuttle).
fresh medium will be injected into the chamber on every 3rd mission day.
A photographic record of the cells before one or more medium changes
is required.
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PART II - MEASUREMENTS
On the 5th mission day the medium in CCK-#2 is removed for storage
and cells are washed in electrophoresis buffer [EB (5.0 mM Hepes) 30
mM Glycine, 0.2 mM KAc, 0.3 mM MgCI2, 0.03 mM CaCI2, 220 mM
Glycerol, 44 mM Sucrose; 0.2 mM Zinc Chloride, 0.1% BSA, pH 7.2;
conductivity 250/Jmhos; Osmolarity; 315 mOsm].
Cells are removed from the polycarbonate substrate by trypsinization and
then washed again in electrophoresis buffer containing DNase. Cell-
washing is accomplished utilizing the unique design of the CCK.
Cells are electrophoresed @ 150V (25 v/cm) at flow of 3 cm/min. The
UV detector captures light scatter signals as cells leave the chamber; a
resulting "scattergram" is viewed by the astronaut in real time. This
determines the position of the 30 collection tubes within the 60 tube
template. Eachcollection tube is charged with serum-containing medium
prior to launch to enable post electrophoresis culture in /Jg in serum-
containing medium.
Cells in the 30 collection tubes are cultured @ 37°C for the remainder
of the flight (except for - the last 24 hours when temperature is
ambient).
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PART III - MEASUREMENTS
on the 5th mission day the medium in CCK-#3 is removed for storage
prior to cell lysis and electrophoresis.
cells are lysed in H20 containing 0.2 mM Zn ÷2 (-5') and the lysate
concentrated by a mechanism TBD (dialysis/filtration are options at this
point).
the lysate is electrophoresed on FFEU (150 V; 25V/cm; 3 cm/min) and
the separation monitored at chamber outlet scattergram technology
described using in Part II measurement (above).
4.3 Test Plan Including Ground Characterization of Flight Hardware
A functional flow diagram of the TX-101 experiment detailed in 4.1 is given
(see next page).
The data in Appendix-Figures 5-23 present results of experiments on the FFEU
hardware that reproduce procedures in Parts I, II, and !I!. These data (to be discussed
at Science Review 1/29/93) show that the new version (12/92) of the CCK will be
suitable for pituitary cells:
• pituitary cells can be: cultured for 5 days; recovered from the flask;
electrophoresed through
electrophoresis for several
sequence for Part II]
the FFEU and finally cultured post-
days [this follows the entire procedural
23
c_. _ __n- o u_
e=
-_ 0 G_ -_o u.
co
g
-J
T
_ 3 _.
L.U
c
_{-_-
_.'N _
o "N tm
_-=_._
_ _-o
._.0_- _
_ _°'-ig °-• -_I_
"_OtO . . 0
T
n
T
• 0
_o
._- ._
.7
_
o
Eo_
8
¢N
o
I
pituitary cell lysates can be prepared from cultured pituitary cells and
subsequently electrophoresed on FFEU. [This follows the entire
procedural sequence for Part Ill].
all of the experiments done on Japanese hardware can be repeated using
hardware at Penn State (i.e. CFES).
4.4 Soecific Analyses Required
See Section 5.8 and Section 4.6.
4.5 Preflight Experiment Planned
Ground operations will in general follow prelaunch procedures developed for the
PHCF experiment for the STS-46 mission (7/92). This includes:
• maintenance of SPF young adult (50 days old) male rats at KSC
• facilities for animal sacrifice
• facilities for preparation of living, sterile pituitary cells
• charging 4-6 CCK with pituitary cells (37°C)
• handover of 3 CCK units (37°C) to appropriate personnel (L-20)
• maintenance of remaining CCK units at temperature i_lentical to those
CCK's on STS (temperature monitoring and recording required
throughout entire mission).
Experimental trials in 1993 will continue to be done on a combination of the
following electrophoresis units:
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1) CFES at Penn State (1.5mm thick chamber)
2) a FFEU prototype which is being built in Japan and is to be installed at
Penn State 2/93 (chamber is 1 mm thick)
3) FFEU flight hardware (2 additional runs in Japan in 1993; 4 mm thick
chamber).
Experimental trials in 1993 will also continue to use several CCK units which
are currently at Penn State. The post-electrophoresis cell/lysate collection tubes will
come to Penn State in 1993, as well as an yet undefined apparatus for lysate
concentration prior to CFE. As of 1/29/93, details of the arrangements for getting the
FFEU prol;otvl3e; cell collection tubes and lysate concentrators tO Penn State are
currently in negotiation between the TX-101 investigator team and NASDA.
4.6 Postfliqht Data Handling and Analysis
The 3 CCK's, 30 collection tubes containing live cells (temperature 22± 1 °C)
and 30 collection tubes containing frozen samples are removed from Shuttle and
transported to Hanger L. The following experimental manipulations are then required:
• cells in CCK from Part I will continue to be cultured in the CCK at 37°C
in Hanger L for an additional 7-14 days. Media will be removed at 3 day
intervals and periodic cell photography will also be done.
• cells in each of the 30 collection tubes from Part II will be centrifuged
(1200 RPM); the supernatant fractions will be frozen for subsequent
analysis at Penn State; cells in the pellets will be prepared for
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morphological analysis (immunocytochemistry) and immunofluorescence
by flow cytometry.
frozen material in the 30 collection tubes from Part II will be shipped to
Penn State for analysis.
Postflight hormone assavs
GH
Enzyme immunoassay (I)
tibial line bioassay (B)
IM-9 lymphocyte bioassay (B)
PR__L
enzyme immunoassay (I)
splenocyte mitogenic assay (B)
Nb-2 mitogenic assay (B)
Other Analyse_
Heat shock protein/chaperone on cell extracts.
Morphology (flow cytometry, immunocytochemistry).
Western Blots/HPLC for hormone variant analyses.
4.7 Mathematical Models Used
None are anticipated, although some data will be interpreted within the context
of Dr. Snyder's data on RAMSES on this same mission. Dr. Snyder is a co-
investigator on the TX-101 experiment.
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4.8 Application of Results
See Section 1.1 and 1.2.
EXPERIMENTAL REQUIREMENTS
5.1 Experiment Sample Reguirements
The samples will be rat pituitary cells in 3 CCK's. Hardware for this experiment
will be provided via NASDA. See Section 4.1 - 4.3 for detailed requirements.
5.2 Atmospheric Requirements
5.2.1 Pressure. Requirement will be the same as for FFEU experiment.
5.2.2 Gas Composition. Atmospheric requirements are compatible with normal
gas composition of Shuttle
5.2.3 Humidity. Requirement will be same as for FFEU experiment
5.2.4 Vacuum. No requirements
5.3 Temperature Control and Measurement
Temperature control within locker holding CCK's must be +0.1°C and
temperature recording must be continuous and tracing provided to PI postflight.
Temperature control and monitoring within FFEU will be done by NASDA.
Temperature in SpaceLab environment must be monitored and recorded.
Pituitary cells are sensitive to increased temperature (above 37°C).
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Ceils collected postflight electrophoresis (in 30 collection tubes) will be returned
to locker and kept at 37±0.1 °C until 10 hr.s. prior to reentry when temperature will
be reduced to 22
phase as well.
requirements).
+ 1°C. Constant recording of temperature is required for this
(The 10 hr. temperature switch is dependent upon NASDA
5.4 Vibration Control and Measurement
Same as for FFEU hardware.
5.5 Test Matrix
See sections 4.1-4.3.
5.6 Imaging Requirements
Cells in CCK will be photographed as described in Section 4.1. Samples
flowing through FFEU will be monitored by UV unit on FFEU and data recorded.
5.6.1 Phot.ographv. Astronaut takes pictures and changes film roles.
Fields of view should be taken through microscope at two magnifications.
5.6.2 Radiography. None
5.6.3 Television. None (?)
5.6.4 resolution. None
5.6.5 Frame rate. None
Ten
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5,7 Electromagnetic limitations. None.
5.8 Astronaut Involvement
5.8.1 Astronaut Involvement
5.8.2 Activation of experiment
Part 1 - CCK #1
I
2.
3.
4.
5.
6.
Remove CCK from 37 ° incubator in locker at MD3.
Remove medium and stow in -20°C freezer.
Add fresh medium to CCK.
Repeat steps 1-3 on MD5 and 8(?).
Switch temperature of incubator to ambient on MD12.
Photograph cells in CCK #1 on MD5.
Part II - CCK #2
1. Remove CCK #2 from 37 ° incubator in locker at MD5.
2. Remove medium and stow in -20°C freezer.
3. Wash cells in electrophoresis buffer - stow wash @-20°C.
4. Add trypsin medium to promote cell detachment. Check for efficiency
of cell detachment by microscopic observation; continue incubation until
completion (usually ~ 15 min.),
5. Remove trypsin medium; stow at -20°C.
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,
9.
10.
Add fresh electrophoresis buffer to CCK (vol -- 5 ml); remove cells into
FFEU sample syringe.
Electrophorese cells."
150V (25 v/cm)
3 cm/min.
UV detector (scattergraph)
Total run time 20 rain. (further discussions with NASDA required)
Collect 30 fractions"
Store 30 fractions in 37°C incubator.
Wash FFEU chamber with electrophoresis buffer.
Part III - CCK #3"
1. Remove CCK from 37°C incubator in locker after Part II electrophoresis
run is completed (MD5)
2. Remove medium and stow at -20°C.
3. Wash cells in CCK in electrophoresis buffer; save electrophoresis buffer
wash at -20°C.
4. Add cell lysis buffer to CCK and monitor cell lysis microscopically until
complete.
" These conditions are not yet defined precisely.
" The scattergraph will define which 30 collection ports to use.
3O
,w
,
8.
Concentrate lysate in concentration hardware (further discussions with
NASDA required).
Electrophorese lysate.
150V (25 v/cm)
3 cm/min.
UV detector (scattergraph)
total run time 20 min (further discussions with NASDA required)
Collect 30 fractions.
Store 30 fraction tubes @ -20°C.
5.9 Data Reauire. ments
1. Voice communication with astronaut will be required during Parts II and
III.
2. Photography of cells in CCK required
3. Temperature monitoring and recording of cells in 37 ° incubator and
when cells are required to be kept at ambient temperature.
4. Monitor scattergram development for Parts II and 111 and keep
photographic record.
5.10. Telepresence and Telerobotics
None.
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6.0 Principa. I Investigator's Requirements
6.1 Research Equipment
6.1.1 Prefliaht. Items of equipment required for the preparation of live, sterile
rat anterior pituitary cells will be furnished from the Pl's laboratory and by existing
facilities in the laboratories at Hanger L. The procedures for the preparation of cells
are identical to those used for the STS-46 mission in July, 1992 and can be submitted
under separate cover.
6.1.2 Postflight Cell Culture_. Incubators (37 ° 4- 0.1°C) will be required at
Hanger Lfor 14days in order to complete Part I. Cells in collection tubes from Part
II will be processed at Hanger L before being shipped to Penn State for analysis.
Requirements for this step include access to clinical centrifuge, refrigerator and phase
microscope. Final sample processing will be at Penn State. Samples collected from
parts I, II, and III which are stored frozen on Shuttle will be kept in frozen state until
analysis at Penn State. Samples from other parts I, II, III which were at 37°/or
ambient will be maintained at 22 4- 1.0°C between time of landing and processing
in Hanger L.
6.2 Apparatus Design Assistance
The PI is working closely with Dr. Snyder (MSFC) and Dr. Nagoaka (NASDA)
to ensure that a prototype FFEU reaches Penn State soon after the science review for
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TX-101 on January 29, 1993 in Huntsville. Placement of this item at Penn State is
absolutely critical for eventual experiment success.
Any further delays will begin to impact negatively on the success of this goal.
6.3 Consultation
None; but note that the
teams.
PI team interacts closely with NASDA and MSFC
6.4 Grant
A 2.7 year proposal to accomplish TX-101 was sent to NASA Headquarters
from Penn State in December 1992. Without full funding this experiment will not be
possible.
6.5 Services
None, other than has been specified and detailed throughout the document.
7.0
to meet experimental objectives/hypothesis testing.
because conditions surrounding the actual flight
mimicked
Other Requirements
It will be necessary to do ground-based control experiments post flight in order
This must be done post flight
experiment must be faithfully
(e.g. timing of the execution of the numerous experimental subtopics;
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temperature; etc). These postflight ground control trials will therefore be
asynchronous and primarily involve TX-101 Parts II and III. Since Part I is done
entirely in CCK's, it may be possible to do synchronous controls and our experimental
scheme provides for this opportunity; however, a successful effort will be dependant
uDon accurate temperature downlinks during the course of the flight. At the time of
writing this document the PI is uncertain as to the feasibility of this requirement.
It will be necessary to repeat Parts II and III using the actual flight unit (FFEU);
ideally this should be done in the Hanger L laboratories at KSC postflight. Since the
thickness of the chamber of the flight unit is 4 ram, it will not be possible to flow
cells/particles without significant flow distortions. Indeed, this is part of the
justification (and advantage) for spaceflight electrophoresis. The thickness of the
FFEU model that the PI team used in Japan on 11/92 to generate the data presented
in the Appendix was 1 mm. Postflight trials will also be done in the Pl's laboratory
at Penn State using the FFEU prototype (chamber thickness lmm).
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APPENDICES 5-23
Preflight experiment
Part 1
Cell Culture Kit (CCK)
7
2-4x10 /CCK
Media change
every 3 days
(5- 13 days)
37°C
in 95% air + 5% CO 2
Cell recovery
by trypsinization
(5 days)
Cell lysis
(5 days)
° Cell morphology
• GH EtA
° Cell recovery / viability
• Lysis
* First available 12 / 92

Summary of FFEU cell culture kit (CCK) experiments
Attempt #
1
2
3
4
5
# Cells
22 x 10 6
22 x 10 6
22 x 10 6
40 x 10 6
22 x 10 6
Days in culture
5
5
13
5
5
%Recovery * % Viability
0.85 82
3.4 87
12 85
30 99
ysis complete after 10 minutes**
* - 15 minutes for trypsinization
** ~ 10 mts of lysis buffer
8000
6000
E
4000
I
2000
Culture media recovered from CCK
(complete media changeout at days indicaed)
22 x 10_ cells
3 6
[] ngGH/ml/day
9
Day
13
Preflight experiment
Part 2
7
2 x 10 /T-25
(3 T-25's)
5 days
Cell recovery
by trypsinization
Cell wash in
EB + DNAse
3 runs on FFEU 1
mm Chamber
(70 minutes / run)
4 ° C
0V
25 Wcm
25 V/cm
0V-IF
25 V/cm - IF
25 V/cm - Culture 2 days
GH (I)
Prl (I)
Prl (Nb-2)
Prl (Mitogen)
' _ Time
(80 minutes)
Time
(80 minutes)
Mobility
(Zero V/cm) f
Mobility
(25 V/cm) f
o
t-
t_
6,1(,3
300
2OO
100
0
50
Cell count
Q_ , , o
Cell recovery 13% of
applied cells
Cell viability >90 %
o_o.._.-,o._o_
40
3O
2O
%
0
I=:
O3
0
0 0 0
I I I I I I
z
t--
z
r-
z
5OO
400 -
3OO
200
100
0
500
4OO
30O
2OO
_°°t
500
4O0
3OO
2OO
IO0
0
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Total
(Medium+cellextracts) y_
Medium
Extracts
_
34 36 38 40 42 44 46
Start EB Wash
Fraction # 37 Fraction # 38 Fraction # 39
Experimental Series A
CFES
Fresh cell
suspension by
trypsinization
Cell
wash in
EB
0V
25 V/cm
Cell counts
GH -IF
¢j')
(B
-r
(3
75-
70 -
65 "
6O
55
50
45 "
40
35
30-
25.
20,
15-
lO
5
GH Cell distribution of separation on CFES
Freshly dispersed pituiary ceils
)
¢D
J_
Fraction
(._
._1
ii
35136
Peak Chpnnel 28,18
• •"- _."_ _.l..
r ; '" ".';_ .. , :-.-.
.... "'•.':.: r-,..o e o'.
• _:;._ _ ;.
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:":":"" __'r :
r r:.., . ,.
_. :..- ....
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'.°r ,: • "
i-, r
._- ...y;:,_:-,._... -"
90 ° Ught Scatter
40
...... ,-..,
• " 23,16
-.
';o
e r" :': '
• :- :" , :
"" ":"-'_ _x': ": " ""
"* _r °
Total cell population
46 / 47
..... . .:, ..;; ..°
28,2t
• iT•:,•-)
• - . . ::,f.:,:,_: .'.:.. •
:L/_j.,:_._ !_
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Experimental Series B
7
2x10 /Flask
(T-25 flasks)
5 days
Cell recovery
by trypsinization
Cell
wash in
EB
0V
25 V/cm
(70 minutes / run)
Culture
7 days
GH (I)
Prl (I)
Prl (Nb-2)
Prl (Mitogen)
leo
zo
_--o"
0 ×
Experimental Series B
8-
6-
4-
2
0
0
Cell Counts
20
t-
O
"5
"E"
Recovery 5 %
Viability >80 %
40
L.......................................................
[IIX Z I I I X I _llll]llll [I _] I Z X ! I I I I I i I I ZX I I I 1 il X I1_[11 I 1 I ]J- - i
60 80 1O0
t-
O
"5
-t-
t-
5000 -
4OOO
3000
2OOO
1000
0
Day 7 culture media
GH (i) 35^v
|11
t-
O
¢U
t-
O 10 20 30
37
[ [ [ [ [ [ [ [ [ ( [ [ [ [[][ [ [ [c[ [-[[ [ [ [[[[( ( [ [-[_-[-[[ [ [ [ [_cc(-[ [ ['[ [ [ [ }
40 50 60 70 80 90 1O0
t-
O
"5
0
t,_
n
t-
5OO
400
300
20O
100
0
Day 7 culture media
Prl (i)
t-
O
"5
t-
O 10 20 3O
38
)
i
I
.,..([[[[[[[[[[[[[[[[[[[([[[[[[[[[[[[[[[[[[{[[[[[[['['['[['[-[[[[[[[[[3
40 50 60 70 80 90 100
Eo
z o
_--o"
O x
¢..
.O
"5
-I-
(5
t-
GH content of media after separating cells on CFES
In culture for 7 days
8-
6-
4-
2,
0,
0
Cell Counts
2O
t-
O
.._
"E"
38
l
I
4O 60 80 100
Day 7 culture media
sooo_ GH (i) 35,-.,
,ooo
3000
t-
O
2000, "_
"E"
IO01 -_ _n
0 10 20 30
37
40 50 60 70 80 90 100
sooo Experiment #2
t-
._.O
"1-
(5
t-
40O0
3000
20OO
1000
t-
O
-.__,
to
"E"
0
3O
10 20 30 40 50 60 70 80 90 100
Fraction
Ceil viability in FFEU collection tube
2 x 10 6 cells
in 5 mls of
EB + culture
media in 1 tube
37 o C in 95% air / 5% CO 2
Remove 0.5 ml
every other day
for 9 days
Cell count
Viability
Cells recovered as a percent of cells seeded
100
90
8O
70
60
t-_
O
or"
C)
5O
40
_ , , i o
100
9O
8O
70
6O
5O
4O
3O
2O
10
0
2 4 6 8 9
Day
Viability of recovered cells
2 4 6 8 9
Day
Conclusions: 1) Cells may "stick" to membrane
2) awaiting additional collection tubes from NASDA
3) Possibilities to increase cell recovery
• washing • trypsinization (TBD)
Preflight experiments for Part 3
7
2x10 /Flask
(T-25 flasks)
5 days
(2 exp's)
Cell wash in EB
Cell lysing in
H 2° -t- 0.2
mM ZnCl 2
Lysis complete in 5 minutes
1/2
* DNAse +
0.1% calf
serum
* DNAse in lysing solution? (TBD_
FFEU
0V
25 V/cm
42 V/cm
GH (I)
Prl (I)
Prl (Nb-2)
Prl (Mitogen)
CFES
0V
25 V/cm
GH (I)
Prl (I)
Prl (Nb-2)
Prl (Mitogen)
T
(5
1500
1200
900
600 -
300.
O.
20
Separation of lysate on FFEU
0 V/cm
•-_o,.o.o-o _..o,o -o-o-o-o,o-o-o -o-o ,o-o-o.,o .o.,o--o-o
25 30 35 40 45 50
"1-
Fraction
1500
1200
900
600-
0,_
20
Separation of lysate on FFEU
25 V/cm
25 30 35 40 45 50
Fraclion
20000 -
15000.
10000.
5OO0
0
20
Separation of lysate on CFES
25 V/cm
25 30 35 40 45 50
FRACTION
I
1500-
1200.
900.
_2
Separation of lysate on FFEU
42 V/cm
E
300-
0- .-.--.O,.O-O-O_ • , . , -O.,,O..O-O-.O-O.,O-O',O
20 25 30 35 40 45 50
% Processed % GH Recovered(Total)
FFEU 13 150
CFES 69 180
Fraction FFEU: 2.7mls_1.35ml-_-_O.177ml/run @ 0.t5mllhr
CFES 5.4 mls "'-- 3.75 ml / run @ 2.5 mt / hr
5O
Lysate separated on CFES
t-
O
(3
,m
oi
4O
30
2O
10
1 -25 26-50 51-75 76-100
300 -
Lysate separated on CFES
t-
O
u 200 '
,1-
(3
J_
01
1O0 '
1 - 25 26- 50 51 - 75 76- 100
C
0
(J
(D
"T-
O
m
r-
r-
0
U
L.
a.
01
C:
20000
18000
16000
14000
12000
10000
800O
6000
4000
2000
0
2000
1800
16OO
1400
1200
1000
800
6OO
4OO
2OO
0
CFES Separation of pituitary cell lysate
25 volts / cm
GH (I)
34
._o
31
0 10 20 30 40 50
FRACTION
CFES Separation of pituitary cell lysate
25 volts / cm
PRL (I)
60 70 80 90 100
34
0 10 20 30 40 50 60 70 80 90 1O0
FRACTION
rt
.>
"5
t_
¢,-
E
E
400,
300-
..¢
200-
==
100-
500.
400-
3oo 
200.
0 V/cm
500. <_
c
20 25 30 35 40 45 50
Fraction
Separation of lysate on FFEU
25 V/cm
A i
0-
20 25 30 35 40 45 50
5OO
Separation of lysate on CFES
25 V/cm
4OO
300-
200-
100-
2O 25 3O 35 4O 4.5 5O
Fraction Fraction
500 -
400.
3OO-
200 -
100-
o_
2O
Separation of lysate on FFEU
42 V/cm
)-o-o,o-o-0-o-o ,,o-o-0-o -o,o-o _-o-o,-o-o-o -o-o-,o-o_
25 3O 35 40 45 50
Fraction
% Processed
% Prl Recovered
(Total)
FFEU 13 7.8
CFES 69 1.8
FFEU: 2.7mls_l.35ml_O.177ml/run @ O.15ml/hr
CFES 5.4mls r- 3.75ml/run @2.Sml/hr
120
1O0
8O
6O
40
20
0
2O
Separation of lysate on FFEU
42 V/cm
_ ng Prl (i) / fraction
_ / 1 "---'e--- ng Prl Nb'2 / fractiOn
25 30 35 40 45 50
FRACTION
8
q,
2OOO
1750
1500
1250
1000
75O
5OO
25O
0
Separation of lysate on CFES
25 V/cm
ng Prt (i) / fraction
ng Prl Nb-2/fraction
_, qp. • ,w _ 11r .w .v.,w w
20 25 30 35 40 45 50
FRACTION
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• Relative to cells in standard culture medium (SMEM), recovery is
consistently superior in D2/AI electrophoresis buffer vs. that in
Goodwin, Harming or STS-8 buffers (Fig. I). Storage temperature
has little effect on cell recovery. Figure i represents an average
of three experiments.
• Ceil viability, relative to that in SMEM, is agaln best in D2/AI
buffer (Figure 2).
• Storage of cells in D2/AI buffer for 72 hours at 4°C is the best
combination of conditions tried to date.
• Application of rat pituitary homogenates (prepared in 0.25M sucrose
+ 2 mM 2 nCL2) to the McDonnell Douglas continuous flow
electrophoresis (CFE) unit yields several peaks of particles
containing rat growth hormone (GH). These are incompletely
separated and show anodal migration (Figure 3; zero tube is #23,
24). MES-gly buffer. Results are repeatable.
• Application of a 40,000 x g pellet fraction (known to be enriched
in secretion granules) to the McDonnell Douglas CFE Shows
separation of a major GH-containing partial peak (~ Fr. 40-55) and
a minor one just anodal to the injection part.
• These electrophoresis results show that granules can be separated
by CFE.
• Four electrophoresis buffers were tested for effects on splenocyte
viability and recovery at two temperatures 4°C and 22°C and over a
period of four days. Buffers were compared to phosphate buffered
saline (PBS) a standard, isotonic cell culture buffer.
• Cell viability was very poor after 24 hours at 22°C in all
electrophoresis buffers (Figure 5). Therefore no further studies
were done at 22°C. At 4°C the best buffer for recovering viable
cells was D2/AI (Figure 6).
• Mitogen assays were performed on cells after 24 hours in Goodwin's
buffer which had high viability in spite of low recovery. Cells
responded to Concanavalin A. The other buffers are yet to be
tested.
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I. Survival of splenocytes after incubation in various electrophoresis buffers
at 22°C for up to 96 hr.
Rat splenocytes (5 x I0 B viable cells/ml) in approximately 20 mls, were
incubated in 30 ml syringes, at 22° in various electrophoresis buffers for 24,
48, 72, and 96 hr. At each time beginning at time O, a sample (0.i - 0.5 ml)
was taken and the cells counted with a hemocytometer. Trypan blue dye exclusion
was used to determine cell viability. Dulbecco's phosphate buffered saline (PBS)
was used as a control cell culture buffer. The electrophoresis buffers included
modifications of D-2/A-I, STS-8, Hannig and Goodwin.
Results:
After 24 hrs in all buffers, there was a rapid decline in cell viability
(Fig. I). PBS gave the best cell recovery, 14% after 24 hrs. D-2/A-I was
similar. The other three buffers gave 4% or less in this time. At 72 hr cells
were seen only in PBS and there the levels were 4%.
This experiment was done twice with similar results.
2. Survival of lymphocytes after incubation in various electrophoresis buffers
at 4° for up to 96 hr.
Rat splenocytes (5 x 106 viable cells/ml), 20 mls, were incubated in 30 ml
syringes at 4° for 24, 48, 72, or 96 hr. At each time beginning at time 0,
samples were taken and the cells counted with a hemocytometer. Trypan blue dye
exclusion was used to determine viability. Dulbecco's phosphate buffered saline
(PBS) was used as a control, cell culture buffer. The electrophoresis buffers
were: D-2/A-I, STS-8, Hannig and Goodwin.
Results:
After 24 hr the recoveries in PBS and D-2/A-I were similar, approximately
77% (Fig. 2). Recovery in the other three buffers ranged from 40 to 60%. After
48 hr, the recovery declined to 65% in PBS, (best recovery); to 26% in Goodwin
buffer, (worst recovery). Even after 96 hr, recovery in PBS was 46%, and in D-
2/A-I, it was 30%. It was down to 10% in Goodwin buffer. This experiment was
done 5 times.
3. Optimization of mitogen responses.
Splenocytes (1.25 x lOB/ml) were incubated at i00 #l/well, 96 well plates,
in RPMI-1640 medium at 37° in an 5% CO2, 95% air, humidified incubator. Cultures
were stimulated with lipopolysaccharide (LPS) from salmonella typhimurium,
dextran sulfate (DEX) or a combination of the two. Other cultures were
stimulated with Concanavalin A, (Con A), or left unstimulated. Cells were
stimulated over a range of concentrations, as shown. Con A is a T cell mitogen;
LPS/Dex a B cell mitogen. 3H-thymidine, (I #Ci/well, specific activity 6.7
Ci/mM) was added at 54 hrs of incubation. At 72 hr the cultures were harvested
onto glass fiber filtermats with a Skatron harvester. The papers were counted
with an LKB Beta plate liquid scintillation counter. The results shown are the
average CPM (3H-thymidine incorporation) of triplicate cultures minus the
incorporation of unstimulated cultures.
Results:
The optimum incorporation for Con A was i #g/ml (Fig. 3a). With LPS/Dex
the highest incorporation was seen with I0 _g/ml each (Fig. 3b). The stimulation
of T cells (Con A) was about 5 fold that of B cells (LPS/Dex).
4. Electrophoretic separation of rat splenocytes on CFES unit PU7.
The concentration of rat splenocytes was adjusted to 1.5 x 107 viable cells
per ml in i0 ml of modified D-2/A-I electrophoresis buffer. Modification of the
original D-2/A-I buffer consisted of lowering the salt concentration and adding
sorbitol (pH- 7.3). Viability of the cell suspension, determined by trypan blue
exclusion, was 93.3%. Cells were collected into a 20 ml syringe and kept at 4°C
through the entire separation procedure. The sample was injected into the CFES
column at 2.5 ml/hour and fractions collected at about 9.0 ml/hour with a
residence time inside the column of about 6.0 minutes. A 90 minute cell
separation followed a 30 minute equilibration of the column. One-hundred
fractions were collected with approximately 12.8 ml total volume each. The total
volume of cell suspension loaded was 3.83 ml (5.75 x 107 total cells). The
fractions were centrifuged at I000 rpm at 4°C and supernatant removed, The
pellet was resuspended in approximately 0.5 ml of PBS with 2% FCS and cells
counted on a hemacytometer. Cell recovery was low; only 7.8 x 106 total cells
were recovered (13.5%) but all cells were viable. The cells were divided equally
for cell surface staining.
Results:
A. Cell distribution and cell recovery
All of the splenocytes were recovered in fractions 34 through 46 (Fig. 4a).
The total cell recovery was low; only 13.5% of the cells loaded were recovered
(4b). Most cells were found in fraction 41.
B. Separation of B and T lymphocytes
Each fraction was divided equally and one stained with antibody (anti CD5)
to T cells, the other with antibody to B cells (Mark -i) (Fig. 5a). A
fluorescent rat anti-mouse IgG (H+L), F(ab')2 was used as a second antibody.
Samples were analyzed by flow cytometry (Epics 753), T cells migrated in the
region of high electrophoretic mobility and B cells in the region of low
electrophoretic mobility.
Unseparated samples contained approximately 809 T cells and 14_ B cells
(Fig 5b). After separation, the B lymphocytes were found mainly in fractions
37 to 39; e.g. Fraction 38 contained 65_ B cells and 26_ T cells. T cells were
enriched in fractions 42 to 44. For example, fraction 43 contained 89_ T cells,
6_ B cells (Fig. 5). There was some overlap.
Problems and Concerns
Cell aggregation at 4° is the major problem.
use of dispase (neutral protease) and DNAase
We are currently testing the
to solve this problem. In
preliminary experiments we have seen promising results.
Plans for Year Two
I. Continue testing the effect of incubation conditions (buffers, temperature,
time) on splenocyte function [i.e. DNA synthesis and interleukin-2 (IL-
2)] release.
2. Cell electrophoresis will be continued and subsets of lymphocytes will be
characterized.
3. Begin work with soluble receptors.
a. Test cell lines for presence of soluble ILo2 receptors.
b. Develop ELISA for detection of soluble IL-2 receptors.
4. Attempt to isolate plasma membranes from primary lymphocytes and lymphoid
lines.
